Updated Aug 23, 2026
/SpaceX's bid to acquire Cognition AI stalls as startup targets $40 billion valuation/Werewolf Therapeutics shares double on Ambros merger and $150 million PIPE/Treasury bond buyback expansion lifts gold and bitcoin as dollar retreats/Brussels weighs crypto lending under MiCA, but DeFi vaults resist easy compliance/Abel leaves Berkshire Hathaway's stock picks to Buffett and portfolio manager Weschler/Chicago Sky guard Natasha Cloud speaks out after three sex toys disrupt WNBA game/SpaceX's bid to acquire Cognition AI stalls as startup targets $40 billion valuation/Werewolf Therapeutics shares double on Ambros merger and $150 million PIPE/Treasury bond buyback expansion lifts gold and bitcoin as dollar retreats/Brussels weighs crypto lending under MiCA, but DeFi vaults resist easy compliance/Abel leaves Berkshire Hathaway's stock picks to Buffett and portfolio manager Weschler/Chicago Sky guard Natasha Cloud speaks out after three sex toys disrupt WNBA game

Heidi Klum, 53, says she has no interest in Ozempic, credits Tom Kaulitz with body-image shift

LOS ANGELES, July 9. At 53, supermodel Heidi Klum has rejected the weight-loss drugs gaining traction in Hollywood, telling Us Weekly she has no interest in Ozempic or other GLP-1 medications. Klum credited husband Tom Kaulitz with…

By Priya Kurup2 min read
Share